Stock Market Investing

Mutual funds come in many packages, all tailored to suit the need of different investors. Biotech mutual funds are a category of these investments, whose major aim is to boost the performance of future technology. They also offer dividends to the investors and other benefits as well. For an investor who may want to invest in these stocks but does not know how to go about it, a little bit of research will go a long way in helping him decide the best way forward.

To begin with, one needs to look out for those investments that have been performing well in the market over the last several years. Do not entirely rely on the performance of the past few years. You can check out for both private (venture capital) and public (NIH) biotech investments. They both seem to be doing well over the years and their value increases with time.

You also need to carefully analyse the profit margin on biotech drugs. Remember that these are products that are always on demand, thanks to the improved technological advances. The profit margin always tends to be on the higher side because of the simple fact that the drugs are cheap to produce, they have a high demand and are always recession proof. A successful drug can have a profit margin of 20 -30 %. Unlike other types of investments, biotech mutual funds have a lower risk factor because testing of the drugs takes about ten years and their probability of not being approved is minimal.

To be able to determine whether an biotech investment is worth your time or not, there are a few questions that should act as your guideline. You must first establish whether the drug can treat a disease that previously had no treatment and how large its market is. You must also establish the possibilities for the expansion of the label or patent of that particular drug whose shares you choose to buy.

Related articles by Zemanta

• Q&A: Why the Stock Market Looks Bullish for Autumn (time.com)
• The other problem with venture capital: management fees (cdixon.org)
• Annuity Sales Recover with Conservative Bent (usnews.com)
• Mutual Fund Terms (shabbir.in)
• Houlihan Smith & Company Senior Managing Director Karl D’Cunha to Speak at the 8th annual World Alternative Investment Summit Canada (prweb.com)
• Target-date mutual funds need vigilance (seattletimes.nwsource.com)
• Leveraged ETFs may not be for you, but they’re not a ’scam’ or a ’scheme’ (seattletimes.nwsource.com)
• Hurt investors seek quick, risky returns (seattletimes.nwsource.com)
• Seed is the new Series A for VCs (innovationtoronto.com)
• Seven Steps to Supercharge Retirement Savings: Independent Financial Professional Provides Strategies to Take Charge of 401(k) Accounts (prweb.com)

Related Posts

• A Look At The Mutual Funds Advantages
• Mutual Funds Are the Way to Go for IRA-401K Funding
• Need for standardisation in mutual funds (Arun)
• Financial Striaght Talk: Financial Investment Retirement Plan: 401k, Bonds, Mutual Funds
• Guide To Buying And Selling Mutual Funds

This entry was posted on Monday, August 31st, 2009 at 10:52 pm and is filed under Mutual Funds. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.